SHAPE PHARMACEUTICALS, INC.

Profile

Company Names

SHAPE PHARMACEUTICALS, INC.

Addresses

55 CAMBRIDGE PARKWAY, SUITE 301, CAMBRIDGE, MA 02142

Phone Numbers

617 997 9881

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$3,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2010-10-01 
$1,000,000.00 
$4,500,000.00 
$3,500,000.00 
Equity 
1
2008-11-18 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
BRADNER 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  SHAPE PHARMACEUTICALS, INC.
AUGUSTINE 
 
LAWLOR 
DIRECTOR
GLOBEIMMUNE INC   |  VAXINNATE CORP   |  STEMGENT INC   |  US GENOMICS INC   |  STEMGENT, INC.   |  PATHOGENETIX, INC.   |  CARDIOVASCULAR SYSTEMS INC   |  SHAPE PHARMACEUTICALS, INC.   |  ANEXON, INC.   |  DEKKUN CORP   |  NANOMR, INC.   |  MOSAIC BIOSCIENCES, INC.   |  APOFORE CORP   |  TENSHA THERAPEUTICS, INC.   |  GITR INC.   |  CATALYST BIOSCIENCES INC   |  LEAP THERAPEUTICS, INC.   |  PAINREFORM LTD.   |  LAYERBIO, INC.
PAUL 
 
MARKS 
DIRECTOR
SHAPE PHARMACEUTICALS, INC.
DOUGLAS 
E. 
ONSI 
EXECUTIVE OFFICER, DIRECTOR
SHAPE PHARMACEUTICALS, INC.   |  DEKKUN CORP   |  APOFORE CORP   |  TENSHA THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-10-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-11-18 
2010-10-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#